RNF41 and cirrhosis of liver: In this study, we demonstrated for the first time that RNF41 methylation levels in PBMCs are significantly elevated in HBV-CLC patients compared to both CHB and HC groups, and systematically evaluated the diagnostic potential of RNF41 methylation as a non-invasive biomarker for HBV-related early liver cirrhosis.